Filtered Listing Testing
Advanced imaging that could lead to a screening test for Alzheimer’s disease (AD), circadian rhythms and their relationship to AD, the importance of clinical trials for developing new AD treatments, and part one of a three-part series on the challenging behaviors associated with AD are among the articles that you will find in the summer 2018 edition of the Alzheimer's Disease Research Review.
Learn about research that is focused on stopping signals that trigger blood vessel growth in wet age-related macular degeneration (AMD), how lifestyle can impact AMD, find helpful information on clinical trials, and more in the summer 2018 edition of Macular Degeneration Research News.
BrightFocus Foundation hosted an awards dinner on June 6 at Washington National Cathedral, to honor leading researchers and advocates working to help end diseases of mind and sight.
BrightFocus Foundation is hosting its third annual dinner to celebrate and showcase some of the world’s most promising science to end Alzheimer’s disease, macular degeneration and glaucoma.
Learn how medications, diseases, and trauma can cause an eye condition called secondary glaucoma, explore how laser procedures are used in the treatment of glaucoma, understand how volunteers are supporting an important clinical trial to save sight, and much more in the spring 2018 edition of National Glaucoma Research Report.
BrightFocus Foundation today announced that EyesOnALZ, the first-ever crowdsourced project to engage the public in Alzheimer’s research, hit a major milestone by exceeding 10,000 citizen scientists joining to help speed up the time-consuming data analysis of stalled blood vessels in the brain. BrightFocus is the key funder of this effort.
An international team of scientists will today receive the prestigious 2018 Helen Keller Prize for Vision Research. The prize, presented by BrightFocus Foundation, honors scientific excellence and is chosen by an awards committee of the Helen Keller Foundation for Research and Education.
BrightFocus Foundation recognizes six scientists studying macular degeneration and glaucoma, awarding research grants named in honor of leaders in vision science.
The world’s largest vision science meeting is about to begin. ARVO 2018 will showcase BrightFocus leadership and the latest advances in macular degeneration and glaucoma research being from achieved by BrightFocus grantees.